Journal of Refractive Surgery
Online Advanced Release
Current Issue
Back Issues
About the Journal
Info for Authors
Contributor Awards
Article Submission
Contact Us
Advertising Info
Article Reprints
Buy a Book
Terms and Conditions
Careers at SLACK Inc.

e-contents - Sign up today
Subscribe to this Journal
Get daily Ophthalmic news at the OSN SuperSite
ISRS: International Society of Refractive Surgery

Faktorovich, Femtodynamics

Reports:
Photorefractive Keratectomy Retreatment After LASIK

Journal of Refractive Surgery  Vol. 24   No. 7   September 2008

See the Full text
Waldir Neira-Zalentein, MD; Jukka A. O Moilanen, MD; Ilpo S Tuisku, MD; Juha M Holopainen, MD and Timo M. T Tervo, MD

Share/Save/Bookmark

 

PURPOSE

To study the results of late photorefractive keratectomy (PRK) in corneas originally subjected to LASIK.

METHODS

Seven eyes of seven patients who had LASIK for myopia were retreated with PRK at least 2 years after LASIK. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), refraction, and haze were evaluated before and after LASIK and after retreatment by PRK.

RESULTS

Photorefractive keratectomy retreatment improved BSCVA in six (86%) of seven eyes, and one (14%) eye showed no changes. None of the eyes lost lines of BSCVA. Five of seven eyes developed mild haze, which disappeared before the last postoperative follow-up.

CONCLUSIONS

Photorefractive keratectomy retreatment performed at least 2 years after LASIK can improve visual acuity. We hypothesize that LASIK-induced corneal nerve damage disturbs corneal wound healing by increasing the tendency for development of haze. [J Refract Surg. 2008;24:710-712.]

ABOUT THE AUTHORS

From the Department of Ophthalmology, University of Helsinki (Neira-Zalentein, Moilanen, Tuisku, Holopainen, Tervo); and Centre for Military Medicine, Aero Medical Center (Moilanen), Helsinki, Finland.

This study was supported by the Helsinki University Research Fund TYH 3316 and 6243, Evald and Hilda Nissi Foundation, Mary och Georg C. Ehrnrooths Foundation; Research Foundation of Orion Corporation; Friends of the Blind Foundation; Leo, Mary and Mary-Ann Hackman Foundation; and the Finnish Eye Foundation.

The authors have no financial interest in the materials presented herein.

Correspondence: Timo M.T. Tervo, MD, Dept of Ophthalmology, University of Helsinki, PO Box 220, 00029 HUS, Finland. Tel: 358 9 471 73109; Fax: 358 9 471 73162; E-mail: timo.tervo@hus.fi

Received: June 20, 2007

Accepted: April 1, 2008

Posted online: May 15, 2008

See the Full text